AI Article Synopsis

  • BioSentinel is NASA's first biological CubeSat, specifically designed to study the impact of deep space radiation on living organisms.
  • The mission aims to autonomously collect data from biological systems over long distances, hundreds of thousands of kilometers away from Earth.
  • The special collection of articles discusses the optimization of BioSentinel's biological payload and offers a look at the evolution of previous biological CubeSat missions, focusing on unique scientific and technological advancements.

Article Abstract

BioSentinel is the first biological CubeSat designed and developed for deep space. The main objectives of this NASA mission are to assess the effects of deep space radiation on biological systems and to engineer a CubeSat platform that can autonomously support and gather data from model organisms hundreds of thousands of kilometers from Earth. The articles in this special collection describe the extensive optimization of the biological payload system performed in preparation for this long-duration deep space mission. In this study, we briefly introduce BioSentinel and provide a glimpse into its technical and conceptual heritage by detailing the evolution of the science, subsystems, and capabilities of NASA's previous biological CubeSats. This introduction is not intended as an exhaustive review of CubeSat missions, but rather provides insight into the unique optimization parameters, science, and technology of those few that employ biological model systems.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10254969PMC
http://dx.doi.org/10.1089/ast.2019.2068DOI Listing

Publication Analysis

Top Keywords

deep space
16
biosentinel biological
8
biological cubesat
8
biological
5
cubesat
4
deep
4
cubesat deep
4
space
4
space exploration
4
exploration biosentinel
4

Similar Publications

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

Background: Cerebral small vessel disease (CSVD), which includes cerebral amyloid angiopathy (CAA) and arteriolosclerosis, often co-occurs with Alzheimer's disease (AD) pathology. The medial temporal lobe (MTL) is susceptible to hosting multiple AD pathologies, such as neurofibrillary tangles (NFTs), amyloid-β plaques, phospho-Tar-DNA-Binding-Protein-43 (pTDP-43), as well as CSVD. Whether a causal relationship between these pathologies exists remains largely unknown, but one potential linking mechanism is the dysfunction of perivascular clearance.

View Article and Find Full Text PDF

Basic Science and Pathogenesis.

Alzheimers Dement

December 2024

Rush University, Chicago, IL, USA.

Background: The aging and dementia field has long been interested in understanding disease heterogeneity, subtypes, and progression. Work has progressed from clinical, to neuroimaging to biomedical devices to neuropathological data, and now brain and blood omic data.

Method: The AMP-AD consortium generated and/or annotated genomic, epigenomic, transcriptomic, proteomic, and metabolomic data from brain and/or blood from thousands of study participants and patients across the 8 teams.

View Article and Find Full Text PDF

Quantum error correction is believed to be essential for scalable quantum computation, but its implementation is challenging due to its considerable space-time overhead. Motivated by recent experiments demonstrating efficient manipulation of logical qubits using transversal gates [Bluvstein et al., Nature (London) 626, 58 (2024)NATUAS0028-083610.

View Article and Find Full Text PDF

Semantic segmentation of high-resolution images from remote sensing is crucial across various sectors. However, due to limitations in computational resources and the complexity of network architectures, many sophisticated semantic segmentation models struggle with efficiency in real-world applications, leading to an interest in developing lightweight model like borders. These models often employ a dual-branch structure, which balances processing speed and performance effectively.

View Article and Find Full Text PDF

Deep generative models have garnered significant attention for their efficiency in drug discovery, yet the synthesis of proposed molecules remains a challenge. Retrosynthetic planning, a part of computer-assisted synthesis planning, addresses this challenge by recursively decomposing molecules using symbolic rules and machine-trained scoring functions. However, current methods often treat each molecule independently, missing the opportunity to utilize shared synthesis patterns and repeat pathways, which may contribute from known synthesis routes to newly emerging, similar molecules, a notable challenge with AI-generated small molecules.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!